Search results
Results from the WOW.Com Content Network
Levonorgestrel is a hormonal medication which is used in a number of birth control methods. [3] [7] It is combined with an estrogen to make combination birth control pills. [8]As an emergency birth control, sold under the brand names Plan B One-Step and Julie, among others, it is useful within 72 hours of unprotected sex.
Plan B One-Step is not the same as the abortion pill and will not affect an existing pregnancy, according to the FDA. The abortion pill involves two different drugs called mifepristone and ...
The "plan B" morning-after pill is a type of emergency birth control, also called emergency contraception, according to the Mayo Clinic, which said it can help prevent pregnancy after sexual ...
FDA Approves Over-the-Counter Availability of Plan B One-Step ® (levonorgestrel) for All Consumers -Plan B One-Step ® will be the First Emergency Contraceptive to be in Store Aisles- NORTH WALES ...
Emergency contraception (EC) is a birth control measure, used after sexual intercourse to prevent pregnancy.. There are different forms of EC. Emergency contraceptive pills (ECPs), sometimes simply referred to as emergency contraceptives (ECs), or the morning-after pill, are medications intended to disrupt or delay ovulation or fertilization, which are necessary for pregnancy.
Before a drug can be prescribed, it must undergo the FDA's approval process. While a drug can feasibly be used off-label (for non-approved indications), it still is required to be approved for a specific disease or medical condition. [2] Drug companies seeking to sell a drug in the United States must first test it.
This greatly expanded and improved version of the database included 1344 approved small molecule drugs and 123 biotech drugs as well as 3037 unique drug targets. Version 2.0 also included, for the first time, withdrawn drugs and illicit drugs , extensive food-drug and drug-drug interactions as well as ADMET (absorption, distribution, metabolism ...
In the United States, the Food and Drug Administration (FDA) determines the requirements for patient package inserts. In the United States, the FDA will occasionally issue revisions to previously approved package inserts, in much the same way as an auto manufacturer will issue recalls upon discovering a problem with a certain car.